These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9550681)

  • 1. The BSM-1 vitamin D receptor polymorphism and secondary hyperparathyroidism.
    McCarey D; Spooner R; Jagger C; McLellan AR; Jardine AG
    Nephrol Dial Transplant; 1998 Mar; 13(3):811-2. PubMed ID: 9550681
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
    Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E
    Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bsm1 vitamin D receptor polymorphism and calcium homeostasis following bariatric surgery.
    Alexandrou A; Armeni E; Kaparos G; Rizos D; Tsoka E; Deligeoroglou E; Creatsa M; Augoulea A; Diamantis T; Lambrinoudaki I
    J Invest Surg; 2015 Feb; 28(1):8-17. PubMed ID: 25180713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.
    Giannini S; D'Angelo A; Nobile M; Carraro G; Rigotti P; Silva-Netto F; Pavan S; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
    J Bone Miner Res; 2002 Oct; 17(10):1768-73. PubMed ID: 12369780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of vitamin D receptor polymorphisms on biochemical markers of mineral bone disorders in South African patients with chronic kidney disease.
    Waziri B; Dix-Peek T; Dickens C; Duarte R; Naicker S
    BMC Nephrol; 2018 Feb; 19(1):30. PubMed ID: 29415666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation.
    Falkiewicz K; Bidzińska B; Demissie M; Boratyńska M; Zmonarski SC; Tworowska K; Klinger M; Milewicz A; Patrzałek D
    Transplant Proc; 2005 Mar; 37(2):1023-5. PubMed ID: 15848611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease.
    Yokoyama K; Shigematsu T; Tsukada T; Ogura Y; Takemoto F; Hara S; Yamada A; Kawaguchi Y; Hosoya T
    Kidney Int; 1998 Feb; 53(2):454-8. PubMed ID: 9461106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for secondary hyperparathyroidism after bariatric surgery: a comparison of 4 different operations and of vitamin D-receptor-polymorphism.
    Toelle P; Peterli R; Zobel I; Noppen C; Christoffel-Courtin C; Peters T
    Exp Clin Endocrinol Diabetes; 2012 Nov; 120(10):629-34. PubMed ID: 23073920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM17, a New Player in the Pathogenesis of Chronic Kidney Disease-Mineral and Bone Disorder.
    Perna AF; Pizza A; Di Nunzio A; Bellantone R; Raffaelli M; Cicchella T; Conzo G; Santini L; Zacchia M; Trepiccione F; Ingrosso D
    J Ren Nutr; 2017 Nov; 27(6):453-457. PubMed ID: 29056164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of secondary hyperparathyroidism in sub-group of vitamin D deficient postmenopausal women: Is VDR gene polymorphism behind this mystery?
    Dixit V; Tripathi RL; Dhanwal DK
    Diabetes Metab Syndr; 2022 Jan; 16(1):102381. PubMed ID: 34995987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor gene polymorphisms affect secondary hyperparathyroidism in hemodialyzed patients.
    Nagaba Y; Heishi M; Tazawa H; Tsukamoto Y; Kobayashi Y
    Am J Kidney Dis; 1998 Sep; 32(3):464-9. PubMed ID: 9740163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene polymorphism of the vitamin D receptor, vitamin D-binding protein and calcium-sensing receptor in respect of calcium-phosphate disturbances in chronic dialysis patients].
    Grzegorzewska AE; Ostromecki G
    Przegl Lek; 2013; 70(9):735-8. PubMed ID: 24455835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary hyperparathyroidism is associated with vitamin D receptor polymorphism and bone density after renal transplantation.
    Rubello D; Giannini S; D'Angelo A; Nobile M; Carraio G; Rigotti P; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Nibale O; Carpi A
    Biomed Pharmacother; 2005 Aug; 59(7):402-7. PubMed ID: 16084056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T; Rastad J; Szabó E; Westin G; Akerström G
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parathormone as a uremic toxin. Physiopathological bases and general therapeutic guidelines].
    Brancaccio D; Galmozzi C; Pizzocaro G
    Minerva Med; 1985 Mar; 76(9-10):377-82. PubMed ID: 3982693
    [No Abstract]   [Full Text] [Related]  

  • 16. BB genotype of the vitamin D receptor gene polymorphism postpones parathyroidectomy in hemodialysis patients.
    Borràs M; Torregrossa V; Oliveras A; Almirall J; Ma Paz M; Betriu A; Martin M; Muray S; Fibla J; Fernández E
    J Nephrol; 2003; 16(1):116-20. PubMed ID: 12649542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vitamin D receptor gene polymorphism and parathyroid function.
    Jofré R; Menárguez J; Polo JR; Arribas B; Cristóbal E; Lopéz-Gómez JM; Valderrábano F
    Nephrol Dial Transplant; 1999 May; 14(5):1336-7. PubMed ID: 10344401
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary hyperparathyroidism is not always an obstacle to improved growth during recombinant human growth hormone treatment.
    Picca S; Perruzza I; Cappa M; Rizzoni G
    Nephron; 1997; 75(2):239-40. PubMed ID: 9041550
    [No Abstract]   [Full Text] [Related]  

  • 19. Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism.
    McCann LM; Beto J
    J Ren Nutr; 2010 May; 20(3):141-50. PubMed ID: 20303786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.